Transcatheter chemoembolization for unresectable hepatocellular carcinoma and comparison of five staging systems
β Scribed by Tomokazu Kawaoka; Hiroshi Aikata; Shintaro Takaki; Yoshimasa Hashimoto; Yoshio Katamura; Akira Hiramatsu; Koji Waki; Shoichi Takahashi; Koji Kamada; Mikiya Kitamoto; Toshio Nakanishi; Masaki Ishikawa; Masashi Hieda; Hideaki Kakizawa; Junko Tanaka; Kazuaki Chayama
- Book ID
- 118088335
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 403 KB
- Volume
- 40
- Category
- Article
- ISSN
- 1386-6346
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Many liver staging systems have been proposed for patients with hepatocellular carcinoma after locoregional therapy; however, controversies persist regarding which system is the best. In this study, the authors compared the performance of 7 staging systems in a cohort of
## Comparison of 7 Staging Systems for Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization I n a recent article in Cancer, Cho and colleagues 1 suggested that the Cancer of the Liver Italian Program (CLIP) system was the best prognostic system for predicting the survi
## Abstract ## BACKGROUND: Radiofrequency ablation (RFA) is becoming a wellβknown local therapy for hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization (TACE) is expected to enhance the effects of subsequent RFA by reducing arterial blood flow. However, the longβterm efficacy
## Comparison of 7 Staging Systems for Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization I n a recent article in Cancer, Cho and colleagues 1 suggested that the Cancer of the Liver Italian Program (CLIP) system was the best prognostic system for predicting the survi